[Cortexin in the comprehensive therapy of alcoholic encephalopathy].
Masaleva IO, Ivenkov MP · 2026 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2026
Study findings
Cognitive test scores improved over ten days in both Cortexin groups during combined detoxification, metabolic and hepatoprotective care.
- Population and setting
- 40 patients with alcoholic encephalopathy; two Cortexin-dose groups
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- No Cortexin-free comparator; improvement cannot be attributed to Cortexin.
- Concurrent treatment and very short follow-up limit interpretation.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed record and abstract checked. Full methods and risk of bias have not been independently assessed.
Recorded source-check date: 2026-10-06. This date does not imply a completed systematic review.
Citation and original source
Original source: Masaleva IO, Ivenkov MP. [Cortexin in the comprehensive therapy of alcoholic encephalopathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova; 2026 2026.
Molekul research summary: https://molekul.io/research/recent-42360215. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry